Simon Quick Advisors LLC Takes Position in CVS Health Corporation (NYSE:CVS)

Simon Quick Advisors LLC acquired a new position in CVS Health Corporation (NYSE:CVS - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 8,014 shares of the pharmacy operator's stock, valued at approximately $543,000.

A number of other hedge funds also recently made changes to their positions in the stock. Stonebridge Financial Group LLC purchased a new position in CVS Health during the fourth quarter valued at approximately $28,000. Hopwood Financial Services Inc. bought a new position in CVS Health in the 4th quarter worth $29,000. McIlrath & Eck LLC increased its stake in CVS Health by 32.6% in the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after buying an additional 174 shares in the last quarter. MV Capital Management Inc. raised its holdings in CVS Health by 63.9% during the first quarter. MV Capital Management Inc. now owns 741 shares of the pharmacy operator's stock valued at $50,000 after acquiring an additional 289 shares during the period. Finally, Financial Perspectives Inc lifted its position in shares of CVS Health by 137.5% in the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after acquiring an additional 466 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other CVS Health news, Director Guy P. Sansone bought 1,570 shares of the company's stock in a transaction on Thursday, June 5th. The stock was acquired at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the transaction, the director now directly owns 12,007 shares of the company's stock, valued at approximately $764,845.90. This represents a 15.04% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 1.22% of the stock is currently owned by corporate insiders.

CVS Health Trading Down 0.9%

CVS stock traded down $0.58 during midday trading on Tuesday, reaching $67.13. 6,092,804 shares of the company traded hands, compared to its average volume of 10,958,365. The firm has a market capitalization of $84.92 billion, a price-to-earnings ratio of 16.02, a P/E/G ratio of 0.97 and a beta of 0.56. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82. The business has a 50 day moving average of $65.09 and a 200-day moving average of $60.25. CVS Health Corporation has a 52-week low of $43.56 and a 52-week high of $72.51.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 10.59% and a net margin of 1.39%. The company had revenue of $94.59 billion during the quarter, compared to the consensus estimate of $93.07 billion. During the same period last year, the company earned $1.31 earnings per share. CVS Health's revenue was up 7.0% on a year-over-year basis. As a group, sell-side analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Tuesday, April 22nd. This represents a $2.66 annualized dividend and a yield of 3.96%. CVS Health's payout ratio is 63.48%.

Wall Street Analysts Forecast Growth

CVS has been the subject of several recent analyst reports. Wall Street Zen upgraded CVS Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. UBS Group upped their target price on shares of CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a research report on Friday, May 2nd. Barclays set a $79.00 price target on shares of CVS Health and gave the company an "overweight" rating in a report on Monday, June 2nd. Argus set a $77.00 price objective on shares of CVS Health in a report on Tuesday, February 18th. Finally, Robert W. Baird lifted their target price on CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a report on Tuesday, April 15th. Two investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $74.75.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.